Rilapladib (Standard)

Overview

Rilapladib (Standard) is the analytical standard of Rilapladib ( HY-102004 ). This product is intended for research and analytical applications. Rilapladib (SB 659032) is a selective Lp-PLA2 (lipoprotein-associated phospholipase A2) inhibitor with an IC 50 of 230 pM. Rilapladib (SB 659032) is also a PAFR (Platelet Activating Factor Receptor) antagonist.

Application

Products | Products > Signaling Pathways > Others | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Neurological Disease | Products > Research Areas > Inflammation/Immunology | Products > Signaling Pathways > Reference Standards | Products > Signaling Pathways > Phospholipase

Product Information

• Catalog No.: HY-102004R
• CAS No.: 412950-08-4
• Molecular Formula: C40H38F5N3O3S
• Molecular Weight: 735.81
• Purity: 99.98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source